newsfilter
← Latest News
GlobeNewswire·

Nasus Pharma to Participate in Upcoming Investor Conferences

TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal